Brin MF - Search Results

1

Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.

Brin MF, Comella CL, Jankovic J, Lai F, Naumann M; CD-017 BoNTA Study Group. Brin MF, et al. Mov Disord. 2008 Jul 30;23(10):1353-60. doi: 10.1002/mds.22157. Mov Disord. 2008. PMID: 18546321 Clinical Trial.

2

Therapeutic uses of botulinum toxin.

Jankovic J, Brin MF. Jankovic J, et al. Among authors: brin mf. N Engl J Med. 1991 Apr 25;324(17):1186-94. doi: 10.1056/NEJM199104253241707. N Engl J Med. 1991. PMID: 2011163 Review. No abstract available.

3

Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).

Brin MF, Blitzer A, Fahn S, Gould W, Lovelace RE. Brin MF, et al. Mov Disord. 1989;4(4):287-96. doi: 10.1002/mds.870040401. Mov Disord. 1989. PMID: 2811888

4

Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.

Brin MF, Fahn S, Moskowitz C, Friedman A, Shale HM, Greene PE, Blitzer A, List T, Lange D, Lovelace RE, et al. Brin MF, et al. Mov Disord. 1987;2(4):237-54. doi: 10.1002/mds.870020402. Mov Disord. 1987. PMID: 3504553

5

Perioperative use of botulinum toxin for movement disorder-induced cervical spine disease.

Adler CH, Zimmerman RS, Lyons MK, Simeone F, Brin MF. Adler CH, et al. Among authors: brin mf. Mov Disord. 1996 Jan;11(1):79-81. doi: 10.1002/mds.870110114. Mov Disord. 1996. PMID: 8771071

6

Botulinum toxin for refractory vocal tics.

Salloway S, Stewart CF, Israeli L, Morales X, Rasmussen S, Blitzer A, Brin MF. Salloway S, et al. Among authors: brin mf. Mov Disord. 1996 Nov;11(6):746-8. doi: 10.1002/mds.870110627. Mov Disord. 1996. PMID: 8914108 No abstract available.

7

Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.

Lew MF, Adornato BT, Duane DD, Dykstra DD, Factor SA, Massey JM, Brin MF, Jankovic J, Rodnitzky RL, Singer C, Swenson MR, Tarsy D, Murray JJ, Koller M, Wallace JD. Lew MF, et al. Among authors: brin mf. Neurology. 1997 Sep;49(3):701-7. doi: 10.1212/wnl.49.3.701. Neurology. 1997. PMID: 9305326 Clinical Trial.

8

Botulinum toxin: historical perspective and potential new indications.

Jankovic J, Brin MF. Jankovic J, et al. Among authors: brin mf. Muscle Nerve Suppl. 1997;6:S129-45. Muscle Nerve Suppl. 1997. PMID: 9826986

9

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.

Brin MF, Lew MF, Adler CH, Comella CL, Factor SA, Jankovic J, O'Brien C, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M. Brin MF, et al. Neurology. 1999 Oct 22;53(7):1431-8. doi: 10.1212/wnl.53.7.1431. Neurology. 1999. PMID: 10534247 Clinical Trial.

10

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.

Brashear A, Lew MF, Dykstra DD, Comella CL, Factor SA, Rodnitzky RL, Trosch R, Singer C, Brin MF, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M. Brashear A, et al. Among authors: brin mf. Neurology. 1999 Oct 22;53(7):1439-46. doi: 10.1212/wnl.53.7.1439. Neurology. 1999. PMID: 10534248 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters